Publication | Closed Access
Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer
154
Citations
21
References
2011
Year
Tumor BiologyOncologyHealth SciencesGastrointestinal OncologyPreclinical ModelsMedicinePathologyImmune Checkpoint InhibitorCancer TreatmentCancer BiologyRadiation OncologyCancer ResearchHer2-positive Gastric Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1